Skip to content

Anupama Kewalramani, MD

NPI 1194767699ActiveIndividual· Pediatrics, Pediatric Allergy/Immunology· Baltimore, MD

Pediatrics, Pediatric Allergy/Immunology (MD) in Baltimore, Maryland, licensed in MD, with an NPI issued in June 2006. Part D covered 39 prescriptions written in 2024, 90% of them generic. Genzyme Corporation was the largest of 10 companies reporting payments in 2025, $641.14 in all, mostly food and beverage.

Overview

NPI1194767699
StatusActive
Entity typeIndividual
CredentialMD
Sole proprietorNo
NPI issuedJun 11, 2006
Last updated in NPPESNov 6, 2008

Specialties and licenses

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Oct 9, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 10, 2026No match—
New York OMIG · Nov 10, 2026No match—
Ohio Medicaid · Nov 10, 2026No match—
Pennsylvania Medicheck · Nov 10, 2026No match—
Washington HCA · Nov 10, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Enrolled Practitioner - Allergy/Immunology (MD)

Part D prescriptions in 2024

Prescriptions (claims)39 · 53 30-day fills
Total drug cost$5,558
Generic share90% of claims

Medicare sources and data years

Industry payments (Open Payments)

  • 2025$641.14 · 26 payments from 10 companies
  • 2024$781.13 · 30 payments from 9 companies

Top paying companies in 2025

What the 2025 payments were for

  • Food and Beverage$641.14 · 26 payments

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other Pediatrics, Pediatric Allergy/Immunology providers in Baltimore

All Pediatrics, Pediatric Allergy/Immunology providers in Maryland →